Literature DB >> 24061341

Loss of chromosome 4 correlates with better long-term survival and lower relapse rate after R0-resection of colorectal liver metastases.

Nadine Aust1, Silke Schüle, Annelore K Altendorf-Hofmann, Yuan Chen, Thomas Knösel, Olaf Dirsch, Utz Settmacher, Anja Weise, Kristin Mrasek, Thomas Liehr.   

Abstract

PURPOSE: Liver metastases are the major cause of cancer-related death in colorectal cancer patients with a tendency to recur in over 50 % of the cases even after curatively intended surgery. Prognosis after liver resection, however, can neither be based on macroscopic or light microscopic evaluation of the metastases nor on clinical data alone. This is a pilot study in order to determine a potential influence of chromosomal aberrations on overall survival and relapse rate after curative liver resection.
METHODS: Twenty randomly selected cases (10 patients with a survival of more and 10 patients with a survival of less than 5 years after resection) were studied by array comparative genomic hybridization.
RESULTS: The distributions concerning age, gender, stage and grading of primary tumor, percentage of patients with chemotherapy, number and distribution of the liver metastases, Nordlinger and Fong scores showed no differences between long- and short-term survivors and no correlation to any chromosomal aberration. However, the relapse rate of patients with (partial) monosomy 4 was lower and the long-time survival better than in the other patients.
CONCLUSIONS: Loss of chromosome 4 in colorectal liver metastases seems not only to be associated with the progression of the primary tumor as reported in the literature, but also with the long-term survival and the cumulative relapse rate after complete resection of colorectal liver metastases.

Entities:  

Mesh:

Year:  2013        PMID: 24061341     DOI: 10.1007/s00432-013-1505-2

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

1.  Retention of chromosome arm 5q in stage II colon cancers identifies 83% of liver metastasis occurrences.

Authors:  Guy Zeitoun; Bruno Buecher; Jan Bayer; Marie-Laure Tanguy; Gilles Thomas; Sylviane Olschwang
Journal:  Genes Chromosomes Cancer       Date:  2006-01       Impact factor: 5.006

2.  Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.

Authors:  Moritz Koch; Peter Kienle; Ulf Hinz; Dalibor Antolovic; Jan Schmidt; Christian Herfarth; Magnus von Knebel Doeberitz; Jürgen Weitz
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

3.  The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes.

Authors:  Chieu B Diep; Kristine Kleivi; Franclim R Ribeiro; Manuel R Teixeira; Ole C Lindgjaerde; Ragnhild A Lothe
Journal:  Genes Chromosomes Cancer       Date:  2006-01       Impact factor: 5.006

Review 4.  The developing clinical problem of chemotherapy-induced hepatic injury.

Authors:  Charles H C Pilgrim; Benjamin N Thomson; Simon Banting; Wayne A Phillips; Michael Michael
Journal:  ANZ J Surg       Date:  2011-05-17       Impact factor: 1.872

5.  Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?

Authors:  Srinevas K Reddy; Allan Tsung; James Wallis Marsh; David A Geller
Journal:  J Surg Oncol       Date:  2011-08-12       Impact factor: 3.454

6.  Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system.

Authors:  S Iwatsuki; I Dvorchik; J R Madariaga; J W Marsh; F Dodson; A C Bonham; D A Geller; T J Gayowski; J J Fung; T E Starzl
Journal:  J Am Coll Surg       Date:  1999-09       Impact factor: 6.113

7.  Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

Authors:  Myrddin Rees; Paris P Tekkis; Fenella K S Welsh; Thomas O'Rourke; Timothy G John
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

8.  Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases.

Authors:  Ralf Konopke; Stephan Kersting; Marius Distler; Jeannine Dietrich; Jörg Gastmeier; Axel Heller; Eberhard Kulisch; Hans-Detlev Saeger
Journal:  Liver Int       Date:  2008-07-29       Impact factor: 5.828

9.  Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study.

Authors:  F Jeroen Vogelaar; Wilma E Mesker; Arjen M Rijken; Gaby W van Pelt; Antonia M van Leeuwen; Hans J Tanke; Rob A Tollenaar; Gerrit J Liefers
Journal:  BMC Cancer       Date:  2010-04-20       Impact factor: 4.430

10.  A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection.

Authors:  Ikuo Nagashima; Tadahiro Takada; Keiji Matsuda; Miki Adachi; Hirokazu Nagawa; Tetsuichiro Muto; Kota Okinaga
Journal:  J Hepatobiliary Pancreat Surg       Date:  2004
View more
  2 in total

1.  Identification of potential novel drug resistance mechanisms by genomic and transcriptomic profiling of colon cancer cells with p53 deletion.

Authors:  Onat Kadioglu; Mohamed Saeed; Nuha Mahmoud; Shaymaa Azawi; Kristin Mrasek; Thomas Liehr; Thomas Efferth
Journal:  Arch Toxicol       Date:  2021-01-30       Impact factor: 5.153

2.  Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance.

Authors:  Onat Kadioglu; Jingming Cao; Nadezda Kosyakova; Kristin Mrasek; Thomas Liehr; Thomas Efferth
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.